nonarteritic anterior ischemic optic neuropathy semaglutide A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic Semaglutide linked to increased risk

doi: 10.1037/amp0000517 2 CoronelJPinosIAmengualJ

Instead, optogenetic excitation of cerebellar nuclei neurons consistently resulted in an abrupt stop of cerebral seizure activity

Doing so can help you to consume fewer calories and enjoy your meals more

Pep helps you track your Ozempic, Wegovy, Mounjaro, Zepbound, and all other GLP-1 medications with ease

Food and Drug Administration (FDA) approved pharmacotherapy for obesity with concomitant dietary and physical lifestyle modifications in subjects with a body mass index (BMI) of at least 30 kg/m 2 or 27 kg/m 2 in conjunction with any of the following obesity-related comorbidities: T2DM, hypertension, or dyslipidemia